These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
109 related items for PubMed ID: 2822229
1. Rapid screening with indirect immunotoxin for monoclonal antibodies against human small cell lung cancer. Weltman JK, Pedroso P, Johnson SA, Davignon D, Fast LD, Leone LA. Cancer Res; 1987 Nov 01; 47(21):5552-6. PubMed ID: 2822229 [Abstract] [Full Text] [Related]
2. Monoclonal antibodies recognising the cluster 2 antigen associated with human small cell lung cancer mediate the toxic effects of ricin A chain in an indirect assay of immunotoxin cytotoxicity. Derbyshire EJ, Wawrzynczak EJ. Br J Cancer Suppl; 1991 Jun 01; 14():74-7. PubMed ID: 1645578 [Abstract] [Full Text] [Related]
3. Internalization of monoclonal antibodies selected for immunotoxin activity against small-cell lung cancer. Weltman JK, Melucci CL, Chen J, Davidson AE. Hybridoma; 1992 Oct 01; 11(5):547-59. PubMed ID: 1334041 [Abstract] [Full Text] [Related]
4. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach. Tong AW, Lee J, Stone MJ. Cancer Res; 1984 Nov 01; 44(11):4987-92. PubMed ID: 6207911 [Abstract] [Full Text] [Related]
5. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain. Ramakrishnan S, Houston LL. Cancer Res; 1984 Apr 01; 44(4):1398-404. PubMed ID: 6142765 [Abstract] [Full Text] [Related]
6. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies. Bodey B, Siegel SE, Kaiser HE. Anticancer Res; 1996 Apr 01; 16(2):661-74. PubMed ID: 8687112 [Abstract] [Full Text] [Related]
7. Cytotoxic activity of ricin A chain immunotoxins recognising cluster 1, w4 and 5A antigens associated with human small cell lung cancer. Wawrzynczak EJ, Derbyshire EJ, Henry RV, Parnell GD, Smith A, Waibel R, Stahel RA. Br J Cancer Suppl; 1991 Jun 01; 14():71-3. PubMed ID: 1645577 [Abstract] [Full Text] [Related]
8. Markedly different antibody responses to immunized small cell and non-small cell lung cancer cells. Doyle LA, Cuttitta F, Mulshine JL, Bunn PA, Minna JD. Cancer Res; 1987 Oct 01; 47(19):5009-13. PubMed ID: 3040237 [Abstract] [Full Text] [Related]
10. An assay that predicts the ability of monoclonal antibodies to form potent ricin A chain-containing immunotoxins. Till M, May RD, Uhr JW, Thorpe PE, Vitetta ES. Cancer Res; 1988 Mar 01; 48(5):1119-23. PubMed ID: 3257712 [Abstract] [Full Text] [Related]
11. Pharmacokinetics and antitumor activity of a bivalent disulfide-stabilized Fv immunotoxin with improved antigen binding to erbB2. Bera TK, Viner J, Brinkmann E, Pastan I. Cancer Res; 1999 Aug 15; 59(16):4018-22. PubMed ID: 10463601 [Abstract] [Full Text] [Related]
12. Establishment of four mouse hybridoma cell lines producing monoclonal antibodies reactive with ras oncogene product p21. Kuzumaki N, Oda A, Yamagiwa S, Taniguchi N, Kobayashi H, Oikawa T. J Natl Cancer Inst; 1986 Dec 15; 77(6):1273-9. PubMed ID: 3540418 [Abstract] [Full Text] [Related]
13. Generation of monoclonal antibodies against human lung squamous cell carcinoma and adenocarcinoma using mice rendered tolerant to normal human lung. Hanai N, Shitara K, Yoshida H. Cancer Res; 1986 Sep 15; 46(9):4438-43. PubMed ID: 3731100 [Abstract] [Full Text] [Related]
14. Monoclonal mouse antibodies raised against human lung carcinoma. Hellström I, Horn D, Linsley P, Brown JP, Brankovan V, Hellström KE. Cancer Res; 1986 Aug 15; 46(8):3917-23. PubMed ID: 3731064 [Abstract] [Full Text] [Related]
15. In vivo therapy of the BCL1 tumor: effect of immunotoxin valency and deglycosylation of the ricin A chain. Fulton RJ, Uhr JW, Vitetta ES. Cancer Res; 1988 May 01; 48(9):2626-31. PubMed ID: 3258547 [Abstract] [Full Text] [Related]
16. New coupling agents for the synthesis of immunotoxins containing a hindered disulfide bond with improved stability in vivo. Thorpe PE, Wallace PM, Knowles PP, Relf MG, Brown AN, Watson GJ, Knyba RE, Wawrzynczak EJ, Blakey DC. Cancer Res; 1987 Nov 15; 47(22):5924-31. PubMed ID: 3499221 [Abstract] [Full Text] [Related]
17. An immunotoxin cytotoxic for breast cancer cells in vitro. LeMaistre CF, Edwards DP, Krolick KA, McGuire WL. Cancer Res; 1987 Feb 01; 47(3):730-4. PubMed ID: 3492266 [Abstract] [Full Text] [Related]
18. Monoclonal antibodies reactive with small cell carcinoma of the lung. Ball ED, Graziano RF, Pettengill OS, Sorenson GD, Fanger MW. J Natl Cancer Inst; 1984 Mar 01; 72(3):593-8. PubMed ID: 6321841 [Abstract] [Full Text] [Related]
19. Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2. Xu F, Leadon SA, Yu Y, Boyer CM, O'Briant K, Ward K, McWatters A, Zhao X, Bae DS, DeSombre K, Zalutsky MR, Bast RC. Clin Cancer Res; 2000 Aug 01; 6(8):3334-41. PubMed ID: 10955821 [Abstract] [Full Text] [Related]
20. Monoclonal antibodies to human lung tumor antigens demonstrated by immunofluorescence and immunoprecipitation. Brenner BG, Jothy S, Shuster J, Fuks A. Cancer Res; 1982 Aug 01; 42(8):3187-92. PubMed ID: 7046919 [Abstract] [Full Text] [Related] Page: [Next] [New Search]